PPARα-deficiency exacerbates ethanol-induced chronic injury of gastric mucosa in mice

doi:10.16352/j.issn.1001-6325.2023.10.1505

Abstract

Abstract: Objective To investigate the impact and mechanism of peroxisome proliferator-activating receptor α (PPARα) deletion on long-term ethanol-induced gastric mucosal injury in mice. Methods Wild-type and PPARα-knockout mice were treated with ethanol-containing diet and control diet respectively, and randomized into 4 groups. After 16 weeks, the histopathological changes of gastric mucosa were observed. ELISA and RT-qPCR were used to detect the contents and expression of inflammatory factors in serum and gastric tissues. The serum and gastric malondialdehyde(MDA) contents were tested by commercially available kit. Western blot was performed to detect the expression of gastric NF-κB signaling pathway in mice. Results Compared with wild-type mice in ethanol- diet group,PPARα-knockout mice showed more severe gastric mucosal injury and the serum TNF-α,IL-1β and gastric MDA content were significantly increased (P＜0.05); The mRNA of the downstream target genes, TNF-α, IL-1β and ICAM-1, were all significantly increased (P＜0.05). The level of nuclear protein p65 was increased(P＜0.01). Conclusions PPARα-deficiency aggravates ethanol-induced gastric mucosal injury in mice, and the mechanism might be related to the activation of gastric NF-κB signaling pathway.

Key words: PPARα, ethanol, chronic gastric mucosal injury, NF-κB

CLC Number:

R573

HU Xiao, GUO Ran, ZHANG Xuguang. PPARα-deficiency exacerbates ethanol-induced chronic injury of gastric mucosa in mice[J]. Basic & Clinical Medicine, 2023, 43(10): 1505-1511.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2023.10.1505

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2023/V43/I10/1505

References

[1]张雷, 符萌, 张伟, 等. 海藻提取物对小鼠酒精性胃溃疡的保护作用[J]. 中国海洋药物, 2021, 40: 28-34.
[2]Zhao T, Zhang Y, Mu S, et al. Protective effects of genipin on ethanol-induced acute gastric injury in mice by inhibiting NLRP3 inflammasome activation[J]. Eur J Pharmacol, 2020, 867: 172800.doi: 10.1016/j.ejphar.2019.172800.
[3]黄富林, 李辉, 赵燕, 等.中国居民2000—2019年因饮酒导致死亡及寿命年损失情况[J]. 中国公共卫生, 2021, 37: 1489-1494.
[4]Mirza AZ, Althagafi II, Shamshad H. Role of PPAR receptor in different diseases and their ligands: physiolog-ical importance and clinical implications[J]. Eur J Med Chem, 2019, 166: 502-513.
[5]Manoharan I, Suryawanshi A, Hong Y, et al. Homeos-tatic PPARα signaling limits inflammatory responses to commensal microbiota in the intestine[J]. J Immunol, 2016, 196: 4739-4749.
[6]Nakajima T, Kamijo Y, Tanaka N, et al. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage[J]. Hepatology, 2004, 40: 972-980.
[7]Okiyama W, Tanaka N, Nakajima T, et al. Polyenephosphatidylcholine prevents alcoholic liver disease in PPAR alpha-null mice through attenuation of increases in oxidative stress[J]. J Hepatol, 2009, 50: 1236-1246.
[8]Na HK, Lee JY. Molecular basis of alcohol-related gastric and colon cancer[J]. Int J Mol Sci, 2017, 18: 1116-1132.
[9]Amirshahrokhi K, Khalili AR. The effect of thalidomide on ethanol-induced gastric mucosal damage in mice: involvement of inflammatory cytokines and nitric oxide[J]. Chem Biol Interact, 2015,225: 63-69.
[10]沈艳婷, 阙任烨, 陶智会, 等. 纳达合剂对胆汁反流性胃炎大鼠胃黏膜TNF-α、IL-8、ICAM-1及MCP-1的影响[J].上海中医药大学学报, 2015, 29: 55-59.
[11]Lalloyer F, Wouters K, Baron M, et al. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice[J]. Arterioscler Thromb Vasc Biol, 2011, 31: 1573-1579.
[12]Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions[J]. Nat Rev Cardiol, 2021, 18: 809-823.
[13]剌晓琴, 刘一志, 张立超, 等. 谷糠多酚对酒精性胃黏膜损伤的保护作用[J]. 食品科学, 2022, 43: 64-71.
[14]王圣凯, 胡苏琴, 吴玲, 等. miR-138在乙醇诱导的大鼠心肌细胞系H9C2氧化应激中表达增加[J]. 基础医学与临床, 2019, 39: 677-681.
[15]燕军, 白振忠, 格日力. 过氧化物酶体增殖物激活受体α调控心肌线粒体能量代谢的研究进展[J]. 中华高血压杂志, 2021, 29: 121-125.